| Michel Safar, Michael F. O'Rourke - 2006 - 618 pàgines
...events in high-risk patients. N Engl /Med2000;342:145-153. 39. Heart Outcomes Prevention Evaluation Study Investigators. Effects of ramipril on cardiovascular...of the HOPE study and MICRO-HOPE substudy. Lancet 2000;355:253-259. 40. Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, et al. Renoprotective... | |
| Christoph Hasslacher - 2001 - 338 pàgines
...macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. Br Med J 1998; 317: 713-20. 60. HOPE Study Investigators. Effects of ramipril on cardiovascular...HOPE study and MICRO-HOPE substudy. Lancet 2000; 355: 253-9. 62. Goldbourt U, Behar S, Reicher-Reis H et al., for the SPRINT Study Group. Early administration... | |
| J.-M. Ekoé, P. Zimmet, Rhys Williams - 2001 - 458 pàgines
...macrovascular and microvascular complications in Type 2 diabetes: UKPDS 38. BMJ (1998); 317: 703-713. 42. Heart outcomes prevention evaluation (HOPE) study...mellitus: results of the HOPE study, and MICROHOPE sub study. Lancet (2000); 355: 252-259. 43. Remuzzi G, Ruggenenti P. Slowing the progression of diabetic... | |
| Gunter Wolf - 2001 - 278 pàgines
...patients with microalbuminuria. Diabetologia 1996;39:587-593. 60 Heart Outcome Prevention Evaluation Study Investigators: Effects of ramipril on cardiovascular...of the HOPE study and MICRO-HOPE substudy. Lancet 1998;353: 1252-1256. 61 Ruggenenti P, Perna A, Gherardi G, Gaspari F, Benini R, Remuzzi G, On behalf... | |
| Bernard Chanu, Bernard Jacotot - 2002 - 230 pàgines
...randomized trial (FACET) in patients with hypertension and NIDDM. Diabetes Care, 1998; 27 : 597-603. [28] Heart Outcomes Prevention Evaluation (HOPE) study...and MICROHOPE substudy. Lancet, 2000; 355 : 253-259. [29] Syvànne M., Taskinen MR Lipids and lipoproteins as coronary risk factors in non-insulin dependent... | |
| Michel Farnier - 2002 - 132 pàgines
...complications of type 2 diabetes (UKPDS 36) : prospective observational study. Br Med J 2000 ; 321 : 412-9. 18. Heart Outcomes Prevention Evaluation (HOPE) Study...HOPE study and MICRO-HOPE substudy. Lancet 2000 ; 355 : 253-9. 19. American Diabetes Association. Treatment of hypertension in adults with diabetes. Diabetes... | |
| F. Arnold Gries - 2003 - 420 pàgines
...antihypertensive agents on proteinuria in diabetic patients. Am J Hypertens 1994; 7: 84S-92S. |222| Heart Outcomes Prevention Evaluation (HOPE) Study...HOPE study and MICRO-HOPE substudy. Lancet 2000; 355: 253-9. [223| Parving HH, Lehnert H, Brockner-Mortensen J, Gonis R, Andersen S, Arner P, for the Irbesartan... | |
| F. Arnold Gries - 2003 - 420 pàgines
...antihypertensive agents on proteinuria in diabetic patients. Am J Hypertens 1994; 7: 84S-92S. |222] Heart Outcomes Prevention Evaluation (HOPE) Study...HOPE study and MICRO-HOPE substudy. Lancet 2000; 355: 253-9. |223] Parving HH, Lehnert H, Bröckner-Mortensen J, Gonis R, Andersen S, Arner P, for the Irbesartan... | |
| Burton E. Sobel, David J. Schneider - 2002 - 314 pàgines
...results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998; 351:1755-1762. 72. Heart Outcomes Prevention Evaluation (HOPE) Study...the HOPE study and MICRO-HOPE substudy. Lancet 2000; 355:253259. 73. Estacio RO, Jeffers BW, Hiatt WR, Biggerstaff SL, Gifford N, Schrier RW. The effect... | |
| Leonid Poretsky - 2002 - 788 pàgines
...inhibition on diabetic nephropathy. The Collaborative Study Group. N EngI J Med 329:1456-62, 1993. 26. Effects of ramipril on cardiovascular and microvascular...results of the HOPE study and MICROHOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators. Lancet 355:253-9, 2000. • 27. Shindler... | |
| |